Graft Failure
2024 Apr 11. In: Sureda A, Corbacioglu S, Greco R, Kröger N,…
CAR T-cell therapy in aggressive lymphomas-identifying prognostic and predictive markers
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):357-363.…
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Transplant Cell Ther. 2023 Dec 1:S2666-6367(23)01710-4. doi:…
Classic Hodgkin lymphoma
Hematol Oncol. 2023 Dec 1. doi: 10.1002/hon.3239. Online ahead…
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection
Haematologica. 2023 Nov 30. doi: 10.3324/haematol.2023.284154.…
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma
Front Oncol. 2023 Nov 2;13:1197340. doi: 10.3389/fonc.2023.1197340.…
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approach
Lancet Haematol. 2023 Dec;10(12):e1006-e1015. doi: 10.1016/S2352-3026(23)00307-1.ABSTRACTThe…
Prior immune checkpoint inhibitor (ICI) therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry
Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00782-8. doi: 10.1016/j.ijid.2023.11.021.…
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party
Front Immunol. 2023 Sep 27;14:1252811. doi: 10.3389/fimmu.2023.1252811.…
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Nat Commun. 2023 Sep 20;14(1):5825. doi: 10.1038/s41467-023-41562-6.ABSTRACTTumor…
Beyond remission: secondary primary malignancies in patients with lymphoma after autologous haematopoietic stem-cell transplantation
Lancet Haematol. 2023 Oct;10(10):e790-e791. doi: 10.1016/S2352-3026(23)00248-X.…
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study
Transplant Cell Ther. 2023 Sep 1:S2666-6367(23)01508-7. doi:…
